Literature DB >> 3125217

Effects of medium and inoculum variations on screening for high-level aminoglycoside resistance in Enterococcus faecalis.

D F Sahm1, C Torres.   

Abstract

Enterococcus faecalis isolates that are refractory to aminoglycoside-penicillin synergy can be detected by their ability to grow in the presence of high concentrations of aminoglycoside (2,000 micrograms/ml). In past studies investigators have used a variety of media and inoculum sizes to perform high-level aminoglycoside resistance screens, but little is known about how these variations affect test accuracy. We screened 63 E. faecalis strains on different media by using various inoculum sizes and correlated the results with synergy test results obtained by time-kill studies. Screens were done with dextrose-phosphate agar, brain heart infusion agar, Trypticase soy agar with 5% sheep blood, Mueller-Hinton agar with 5% sheep blood, dextrose-phosphate broth, and Mueller-Hinton broth. Agar screens were inoculated with 10(2), 10(4), and 10(6) CFU; and broth screens contained a final inoculum of 10(5) CFU/ml. The E. faecalis isolates were tested for high-level resistance to streptomycin, kanamycin, amikacin, gentamicin, and tobramycin. Of the 63 isolates tested, 21 did not show high-level resistance to any of the aminoglycosides tested, and 42 demonstrated high-level resistance to one or more drugs. The sensitivity of most screens was greater than or equal to 90%. Regardless of the inoculum size or medium used, false-resistance results were seldom encountered. Screen specificity, which was used as the indicator of false susceptibility, was markedly influenced by both the inoculum size and the drug being tested. Specificity was low whenever a 10(2)-CFU inoculum was used, when amikacin was tested with any inoculum, and when tobramycin was tested in broth media. Data for kanamycin could be used to predict amikacin-penicillin synergy, and the highly accurate gentamicin screen obviated the need for the testing of tobramycin. We recommend a 10(6) -CFU inoculum for agar screens and a 10(5) -CFU/ml inoculum for broth screens. The type of medium used did not substantially influence screen accuracy. Among the aminoglycosides, only streptomycin, gentamicin, and occasionally, kanamycin need to be used to screen E. faecalis isolates for aminoglycoside-penicillin synergy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3125217      PMCID: PMC266261          DOI: 10.1128/jcm.26.2.250-256.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  The Combined Action of Penicillin with Streptomycin or Chloromycetin on Enterococci in Vitro.

Authors:  E Jawetz; J B Gunnison; V R Coleman
Journal:  Science       Date:  1950-03-10       Impact factor: 47.728

2.  Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin.

Authors:  S A Calderwood; C Wennersten; R C Moellering; L J Kunz; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

3.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05

4.  Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism.

Authors:  D J Krogstad; T R Korfhagen; R C Moellering; C Wennersten; M N Swartz
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

5.  Penicillin-netilmicin synergism against Streptococcus faecalis.

Authors:  O M Korzeniowski; C Wennersten; R C Moellering; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

6.  Enterococci from Bangkok, Thailand, with high-level resistance to currently available aminoglycosides.

Authors:  B E Murray; J Tsao; J Panida
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

7.  Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci.

Authors:  P Courvalin; C Carlier; E Collatz
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

8.  Aminoglycoside-resistant enterococci.

Authors:  M J Basker; B Slocombe; R Sutherland
Journal:  J Clin Pathol       Date:  1977-04       Impact factor: 3.411

9.  Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes.

Authors:  A E Jacob; S J Hobbs
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

10.  High-level resistance to gentamicin in clinical isolates of enterococci.

Authors:  B D Mederski-Samoraj; B E Murray
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

View more
  37 in total

Review 1.  Screening and treatment of infections caused by resistant enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 2.  Antimicrobial resistance among enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

3.  Comparison of the new MicroScan Pos MIC Type 6 panel and AMS-Vitek Gram Positive Susceptibility Card (GPS-TA) for detection of high-level aminoglycoside resistance in Enterococcus species.

Authors:  S Szeto; M Louie; D E Low; M Patel; A E Simor
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

4.  Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis.

Authors:  D F Sahm; S Boonlayangoor; P C Iwen; J L Baade; G L Woods
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

5.  In vitro activities of 15 antimicrobial agents against clinical isolates of South African enterococci.

Authors:  M C Struwig; P L Botha; L J Chalkley
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

6.  Survey of enterococcal susceptibility patterns in Belgium.

Authors:  P Vandamme; E Vercauteren; C Lammens; N Pensart; M Ieven; B Pot; R Leclercq; H Goossens
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

7.  Comparison of four methods for testing high-level aminoglycoside resistance in enterococci.

Authors:  P Yagupsky; S Petry; M A Menegus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

8.  Evaluation of a commercial microtiter system (MicroScan) using both frozen and freeze-dried panels for detection of high-level aminoglycoside resistance in Enterococcus spp.

Authors:  S A Fuller; D E Low; A E Simor
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

9.  Neonatal bacteremia due to high level aminoglycoside resistant (HLAR) enterococci.

Authors:  K G Bhat; C Paul; M G Bhat
Journal:  Indian J Pediatr       Date:  1997 Jul-Aug       Impact factor: 1.967

10.  In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.

Authors:  D F Sahm; J Kissinger; M S Gilmore; P R Murray; R Mulder; J Solliday; B Clarke
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.